Cannapharmarx Inc (CPMD)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 12-2024 | 12-2023 | 12-2022 | 12-2021 | 12-2020 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -9,906 | 3,689 | -8,531 | -8,833 | -19,890 |
| Depreciation Amortization | N/A | 128 | 774 | 1,258 | 2,422 |
| Accounts receivable | -2 | N/A | N/A | N/A | N/A |
| Other Working Capital | 24 | -821 | 3,948 | -421 | 3,723 |
| Other Operating Activity | 8,186 | -5,270 | 2,361 | 5,581 | 13,181 |
| Operating Cash Flow | $-1,697 | $-2,275 | $-1,448 | $-2,415 | $-564 |
| Cash Flows From Investing Activities | |||||
| PPE Investments | N/A | -81 | -116 | -6 | N/A |
| Net Acquisitions | N/A | N/A | N/A | -40 | N/A |
| Other Investing Activity | 0 | 0 | 0 | 539 | 0 |
| Investing Cash Flow | $N/A | $-81 | $-116 | $494 | $0 |
| Cash Flows From Financing Activities | |||||
| Change In Short Term Borrowing | 150 | 406 | 913 | 584 | 553 |
| Debt Issued | 1,549 | N/A | 55 | 239 | -23 |
| Debt Repayment | N/A | 1,947 | N/A | -255 | N/A |
| Common Stock Issued | N/A | N/A | 437 | 291 | N/A |
| Other Financing Activity | 0 | 0 | 0 | 481 | 295 |
| Financing Cash Flow | $1,699 | $2,353 | $1,405 | $1,341 | $825 |
| Exchange Rate Effect | N/A | N/A | 134 | 273 | 72 |
| Beginning Cash Position | 1 | 2 | 28 | 335 | 2 |
| End Cash Position | 2 | 1 | 2 | 28 | 335 |
| Net Cash Flow | $2 | $-2 | $-26 | $-307 | $333 |
| Free Cash Flow | |||||
| Operating Cash Flow | -1,697 | -2,275 | -1,448 | -2,415 | -564 |
| Capital Expenditure | N/A | -81 | -116 | -6 | N/A |
| Free Cash Flow | -1,697 | -2,355 | -1,564 | -2,421 | -564 |